Provided by Tiger Trade Technology Pte. Ltd.

Iovance Biotherapeutics, Inc.

4.11
+0.410011.08%
Post-market: 4.06-0.0499-1.21%19:59 EDT
Volume:23.10M
Turnover:93.81M
Market Cap:1.84B
PE:-4.43
High:4.20
Open:3.70
Low:3.69
Close:3.70
52wk High:5.63
52wk Low:1.66
Shares:446.50M
Float Shares:388.00M
Volume Ratio:2.50
T/O Rate:5.95%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9281
EPS(LYR):-1.0941
ROE:-47.51%
ROA:-23.65%
PB:2.54
PE(LYR):-3.76

Loading ...

Mar 15, 2021

Major Issues Report

8-K - Current report
Mar 12, 2021

Major Issues Report

8-K - Current report
Mar 11, 2021

Major Issues Report

8-K - Current report
Feb 25, 2021

Major Issues Report

8-K - Current report
Feb 25, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2021

Major Issues Report

8-K - Current report
Feb 09, 2021

Major Issues Report

8-K - Current report
Feb 01, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 29, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 11, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 07, 2021

Major Issues Report

8-K - Current report
Dec 14, 2020

Major Issues Report

8-K - Current report
Nov 05, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 05, 2020

Major Issues Report

8-K - Current report
Oct 14, 2020

Major Issues Report

8-K - Current report
Oct 05, 2020

Major Issues Report

8-K - Current report